Cita APA (7a ed.)
Satapathy, S., Yadav, M. P., Ballal, S., Sahoo, R. K., & Bal, C. (2024). [177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: A real-world study. European Journal of Nuclear Medicine & Molecular Imaging, 51(8), 2495-2504.
Cita Chicago Style (17a ed.)
Satapathy, Swayamjeet, Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, y Chandrasekhar Bal. "[177Lu]Lu-PSMA-617 as First-line Systemic Therapy in Patients with Metastatic Castration-resistant Prostate Cancer: A Real-world Study." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 8 (2024): 2495-2504.
Cita MLA (9a ed.)
Satapathy, Swayamjeet, et al. "[177Lu]Lu-PSMA-617 as First-line Systemic Therapy in Patients with Metastatic Castration-resistant Prostate Cancer: A Real-world Study." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 8, 2024, pp. 2495-2504.
Precaución: Estas citas no son 100% exactas.